Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001171843-19-003097
Filing Date
2019-05-08
Accepted
2019-05-08 08:02:35
Documents
55
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q f10q_050819p.htm 10-Q 511268
2 EXHIBIT 31.1 exh_311.htm EX-31.1 11636
3 EXHIBIT 31.2 exh_312.htm EX-31.2 11523
4 EXHIBIT 32.1 exh_321.htm EX-32.1 6318
  Complete submission text file 0001171843-19-003097.txt   2853139

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE prto-20190331.xml EX-101.INS 430620
6 XBRL SCHEMA FILE prto-20190331.xsd EX-101.SCH 38401
7 XBRL CALCULATION FILE prto-20190331_cal.xml EX-101.CAL 22872
8 XBRL DEFINITION FILE prto-20190331_def.xml EX-101.DEF 259550
9 XBRL LABEL FILE prto-20190331_lab.xml EX-101.LAB 220077
10 XBRL PRESENTATION FILE prto-20190331_pre.xml EX-101.PRE 280151
Mailing Address 200 WEST STREET WALTHAM MA 02451
Business Address 200 WEST STREET WALTHAM MA 02451 781-890-0102
PROTEON THERAPEUTICS INC (Filer) CIK: 0001359931 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36694 | Film No.: 19805239
SIC: 2836 Biological Products, (No Diagnostic Substances)